Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Shree Pushkar Chemicals & Fertilisers Limited (SHREEPUSHK.NS)
Mumbai, IN
Established in 1993 and headquartered in Mumbai, India, Shree Pushkar Chemicals & Fertilisers Limited operates as a manufacturer and trader of a diverse range of products. Domestically, the company markets its offerings under the "Shree Pushkar" brand. Its extensive product portfolio includes various chemicals, specialized dyes such as "DYECOL" reactive dyes, and dye intermediates like H acid, vinyl sulphone, sulpho para base, K acid, and gamma acid. The company also produces a comprehensive selection of fertilizers and soil conditioners, including single super phosphate, sulphate of potash, mono potassium phosphate, monoammonium phosphate, calcium nitrate, and water-soluble fertilizers, as well as nitrogen, phosphorus, and potash formulations. Additionally, Shree Pushkar manufactures industrial acids such as sulphuric, oleum, and chloro sulphonic acids, alongside cattle feed supplements. The firm is also engaged in the export of its products. In March 2012, the company formally changed its name from Shree Pushkar Petro Products Limited to its current designation.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.46% | -5.56% | +3.21% | +6.90% | -13.10% | -9.56% | +21.38% | +93.65% | +102.21% | +198.00% | +466.22% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+21.1% ★ Q1'26: -0.6% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+18.3% ★ Q1'26: -24.6% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+6.8% ★ Q1'26: -1.9% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+7.8% Q1'26: +7.5% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+10.3% ★ Q1'26: +7.9% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+1.1% Q1'26: +3.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×1.32× ★ Q1'26: 1.48× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
Mar 2031 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3.04B
est: 3.13B (-2.8%)
|
3.93B
est: 3.82B (+2.9%)
|
4.46B
est: 4.52B (-1.4%)
|
3.42B
est: 3.51B (-2.3%)
|
3.52B
est: 5.60B (-37.2%)
|
5.81B
est: 5.88B (-1.3%)
|
3.13B
3.13B – 3.13B
-46.8% YoY
|
3.82B
3.82B – 3.82B
+22.0% YoY
|
4.52B
4.52B – 4.52B
+18.2% YoY
|
3.51B
3.51B – 3.51B
-22.4% YoY
|
5.60B
5.60B – 5.60B
+59.9% YoY
|
5.88B
5.88B – 5.88B
+5.0% YoY
|
| EBITDA |
540.20M
est: 379.13M (+42.5%)
|
622.46M
est: 626.28M (-0.6%)
|
688.41M
est: 696.33M (-1.1%)
|
530.05M
est: 740.26M (-28.4%)
|
499.53M
est: 562.52M (-11.2%)
|
860.71M
est: 712.00M (+20.9%)
|
379.13M
379.13M – 379.13M
-46.8% YoY
|
462.46M
462.46M – 462.46M
+22.0% YoY
|
546.83M
546.83M – 546.83M
+18.2% YoY
|
424.13M
424.13M – 424.13M
-22.4% YoY
|
678.12M
678.12M – 678.12M
+59.9% YoY
|
712.00M
712.00M – 712.00M
+5.0% YoY
|
| EBIT |
477.49M
est: 287.98M (+65.8%)
|
544.51M
est: 564.13M (-3.5%)
|
588.79M
est: 624.85M (-5.8%)
|
415.50M
est: 649.25M (-36.0%)
|
373.05M
est: 442.57M (-15.7%)
|
719.34M
est: 529.63M (+35.8%)
|
287.98M
287.98M – 287.98M
-45.6% YoY
|
351.28M
351.28M – 351.28M
+22.0% YoY
|
415.37M
415.37M – 415.37M
+18.2% YoY
|
322.17M
322.17M – 322.17M
-22.4% YoY
|
515.10M
515.10M – 515.10M
+59.9% YoY
|
540.83M
540.83M – 540.83M
+5.0% YoY
|
| Net Income |
302.17M
est: 324.72M (-6.9%)
|
365.49M
est: 367.58M (-0.6%)
|
408.46M
est: 428.69M (-4.7%)
|
357.11M
est: 464.20M (-23.1%)
|
285.37M
est: 407.33M (-29.9%)
|
555.47M
est: 537.27M (+3.4%)
|
324.72M
324.72M – 324.72M
-39.6% YoY
|
371.26M
371.26M – 371.26M
+14.3% YoY
|
479.36M
479.36M – 479.36M
+29.1% YoY
|
334.59M
334.59M – 334.59M
-30.2% YoY
|
527.62M
527.62M – 527.62M
+57.7% YoY
|
537.27M
537.27M – 537.27M
+1.8% YoY
|
| SGA |
71.36M
est: 227.85M (-68.7%)
|
127.59M
est: 353.32M (-63.9%)
|
173.97M
est: 231.06M (-24.7%)
|
226.83M
est: 297.48M (-23.8%)
|
347.18M
est: 407.53M (-14.8%)
|
416.88M
est: 427.89M (-2.6%)
|
227.85M
227.85M – 227.85M
-46.8% YoY
|
277.93M
277.93M – 277.93M
+22.0% YoY
|
328.63M
328.63M – 328.63M
+18.2% YoY
|
254.89M
254.89M – 254.89M
-22.4% YoY
|
407.53M
407.53M – 407.53M
+59.9% YoY
|
427.89M
427.89M – 427.89M
+5.0% YoY
|
| EPS |
10.00
est: 10.09 (-0.9%)
|
12.09
est: 11.54 (+4.8%)
|
13.32
est: 14.90 (-10.6%)
|
11.60
est: 10.40 (+11.5%)
|
9.25
est: 16.40 (-43.6%)
|
18.01
est: 16.70 (+7.8%)
|
10.09
10.09 – 10.09
-39.6% YoY
|
11.54
11.54 – 11.54
+14.3% YoY
|
14.90
14.90 – 14.90
+29.1% YoY
|
10.40
10.40 – 10.40
-30.2% YoY
|
16.40
16.40 – 16.40
+57.7% YoY
|
16.70
16.70 – 16.70
+1.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-20 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-19 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-18 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Deepak Beriwala | Chief Financial Officer | 2M | male |
| Pankaj Manjani | Company Secretary & Compliance Officer | 903.1K | male |
| N. N. Mahapatra | Business Head of Dyes | 139.0K | — |
| Gautam Gopikishan Makharia | Joint MD, Chief Operating Officer & Executive Director | — | male |
| Punit Gopikishan Makharia | Founder, Chairman & MD | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SHREEPUSHK.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
